ALEXIS MOORE: Open Payments
NPI 1720816861 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $106 |
| ABBVIE INC. | 4 | $91 |
| Lundbeck LLC | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: ARISTADA, VRAYLAR, REXULTI, FANAPT, TRINTELLIX, COBENFY, INVEGA SUSTENNA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
